Advanced Biosensors for Virus Detection: Smart Diagnostics to Combat Against the SARS-CoV2 Pandemic covers the development of biosensor-based approaches for the diagnosis and prognosis of viral infections, specifically coronaviruses. The book discusses wide-ranging topics of available biosensor-based technologies and their application for early viral detection. Sections cover the emergence of SARS-CoV, MERS-CoV and SARS-CoV2, the global health response, the impact on affected populations, state-of-the art biomarkers, and risk factors. Specific focus is given to COVID-19, with coverage of genomic profiling, strain variation and the pathogenesis of SARS-CoV2.
In addition, current therapeutics, nano-abled advancements and challenges in the detection of SARS-CoV2 and COVID-19 management are discussed, along with the role of nanomaterials in the development of biosensors and how biosensors can be scaled up for clinical applications and commercialization.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. xvii 7. Preface - p. xxiii 8. Acknowledgments - p. xxv 9. Chapter 1. The emergence of severe acute respiratory syndrome-coronavirus 2 epidemic and pandemic - p. 1 10. Chapter 2. Lesson learned from coronaviruses (SARS-CoV, MERS-CoV, and SARS-CoV-2) and socioeconomic impact of (SARS-CoV-2) pandemic - p. 19 11. Chapter 3. Structure, genomic analysis, and pathogenesis of SARS-CoV-2 - p. 37 12. Chapter 4. COVID-19 diagnosis: approaches and challenges - p. 61 13. Chapter 5. Current therapeutic choices for coronavirus disease 2019: a state-of-the-art review - p. 79 14. Chapter 6. Genomic, proteomic biomarkers and risk factors associated with COVID-19 - p. 95 15. Chapter 7. Biological/synthetic receptors (antibody, enzyme, and aptamer) used for biosensors development for virus detection - p. 113 16. Chapter 8. Potential electrochemical biosensors for early detection of viral infection - p. 133 17. Chapter 9. Optical biosensors for SARS-CoV-2 detection - p. 155 18. Chapter 10. Recent developments of molecular/biosensor diagnostics for SARS-CoV-2 detection - p. 167 19. Chapter 11. Role of magnetic nanoparticles in development of biosensors for viral infection diagnostics - p. 189 20. Chapter 12. Advances in nanomaterials-based biosensors for the development of virus detection - p. 203 21. Chapter 13. Multiplexed biosensors for virus detection - p. 219 22. Chapter 14. Electrical biosensors for virus detection - p. 241 23. Chapter 15. Diagnostic biosensors for coronaviruses and recent developments - p. 261 24. Chapter 16. Fluorescence-based biosensors for SARS-CoV-2 viral infection diagnostics - p. 279 25. Chapter 17. Miniaturized analytical system for point-of-care coronavirus infection diagnostics - p. 305 26. Chapter 18. Microfluidic devices with integrated biosensors for coronavirus infection diagnostics - p. 341 27. Chapter 19. Approaches for fabrication of point-of-care biosensors for viral infection - p. 353 28. Chapter 20. Currently available biosensor-based approaches for severe acute respiratory syndrome-coronavirus 2 detection - p. 373 29. Chapter 21. Biosensors-based approaches for other viral infection detection - p. 391 30. Chapter 22. Scaling up of biosensors for clinical applications and commercialization - p. 407 31. Chapter 23. Future aspects of biosensor-based devices in disease detection - p. 423 32. Index - p. 441
Advanced Biosensors for Virus Detection: Smart Diagnostics to Combat Against the SARS-CoV2 Pandemic covers the development of biosensor-based approaches for the diagnosis and prognosis of viral infections, specifically coronaviruses. The book discusses wide-ranging topics of available biosensor-based technologies and their application for early viral detection. Sections cover the emergence of SARS-CoV, MERS-CoV and SARS-CoV2, the global health response, the impact on affected populations, state-of-the art biomarkers, and risk factors. Specific focus is given to COVID-19, with coverage of genomic profiling, strain variation and the pathogenesis of SARS-CoV2.
In addition, current therapeutics, nano-abled advancements and challenges in the detection of SARS-CoV2 and COVID-19 management are discussed, along with the role of nanomaterials in the development of biosensors and how biosensors can be scaled up for clinical applications and commercialization.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. xvii 7. Preface - p. xxiii 8. Acknowledgments - p. xxv 9. Chapter 1. The emergence of severe acute respiratory syndrome-coronavirus 2 epidemic and pandemic - p. 1 10. Chapter 2. Lesson learned from coronaviruses (SARS-CoV, MERS-CoV, and SARS-CoV-2) and socioeconomic impact of (SARS-CoV-2) pandemic - p. 19 11. Chapter 3. Structure, genomic analysis, and pathogenesis of SARS-CoV-2 - p. 37 12. Chapter 4. COVID-19 diagnosis: approaches and challenges - p. 61 13. Chapter 5. Current therapeutic choices for coronavirus disease 2019: a state-of-the-art review - p. 79 14. Chapter 6. Genomic, proteomic biomarkers and risk factors associated with COVID-19 - p. 95 15. Chapter 7. Biological/synthetic receptors (antibody, enzyme, and aptamer) used for biosensors development for virus detection - p. 113 16. Chapter 8. Potential electrochemical biosensors for early detection of viral infection - p. 133 17. Chapter 9. Optical biosensors for SARS-CoV-2 detection - p. 155 18. Chapter 10. Recent developments of molecular/biosensor diagnostics for SARS-CoV-2 detection - p. 167 19. Chapter 11. Role of magnetic nanoparticles in development of biosensors for viral infection diagnostics - p. 189 20. Chapter 12. Advances in nanomaterials-based biosensors for the development of virus detection - p. 203 21. Chapter 13. Multiplexed biosensors for virus detection - p. 219 22. Chapter 14. Electrical biosensors for virus detection - p. 241 23. Chapter 15. Diagnostic biosensors for coronaviruses and recent developments - p. 261 24. Chapter 16. Fluorescence-based biosensors for SARS-CoV-2 viral infection diagnostics - p. 279 25. Chapter 17. Miniaturized analytical system for point-of-care coronavirus infection diagnostics - p. 305 26. Chapter 18. Microfluidic devices with integrated biosensors for coronavirus infection diagnostics - p. 341 27. Chapter 19. Approaches for fabrication of point-of-care biosensors for viral infection - p. 353 28. Chapter 20. Currently available biosensor-based approaches for severe acute respiratory syndrome-coronavirus 2 detection - p. 373 29. Chapter 21. Biosensors-based approaches for other viral infection detection - p. 391 30. Chapter 22. Scaling up of biosensors for clinical applications and commercialization - p. 407 31. Chapter 23. Future aspects of biosensor-based devices in disease detection - p. 423 32. Index - p. 441
